203-425-1

Applied Filters:

Keyword:'203-425-1'

Showing 1-22 of 22 results for "203-425-1" within Technical Documents

., 75(4), 415-425 (1997). 4. Zhao, S. P., et al., Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia. Clin. Chim. Acta, 203(2-3), 109-117

Product Information Sheet - F3506

Kondo, M. et al., 12th Peptides Symposium, P. 425-426. 13. Schepers, T.M. et al., J. Biol. Chem., 267, 159-165 (1992). 14. Naccache, P.H. et al., Science, 203, 461-463 (1979). 15. Homma, Y. et al., Biochem

Quality Control Range Sheet- MCC-115 and MCC-215

948 pg/mL Control 2 503 - 1045 pg/mL IL-1 Control 1 85 - 176 pg/mL IL-17 Control 1 91 - 189 pg/mL TNF Control 1 88 - 184 pg/mL Control 2

XP725 Antibody Number-Lot Number 071M4826

466 467 468 5.4 397 398 399 400 421 422 423 424 445 446 447 448 469 470 471 472 5.5 401 402 403 404 425 426 427 428 449 450 451 452 473 474 475 476 5.6 405 406 407 408 429

Programming data for Spectrophotometer and Spectroquant Test Kits

18.8 0.464 100 250 140 14.0 17.5 25.0 0.567 120 300 168 16.8 21.0 30.0 0.708 145 363 203 20.3 25.4 36.3 0.862 170 425 238 23.8 29.8 42.5 1.021 195 488 273 27.3 34.1 48.8 1.144 215 538 301 30.1 37.6 53.8

Millistak+®Pod Disposable Depth Filter Performance Guide

µPod® 1 407 441 31 7.1%2 449 3 468 Lot A Lab scale Pod 1 404 427 24 5.6%2 425 3 452 Lot B Lab scale Pod 1 412 425

Product Information Sheet - INHIB1

Calbiochem Biologics 31.2

≥95% by HPLC. M.W. 411.6. Cat. No. 239803 1 mg $ 117 Ref.: Berman, D.M., et al. 2003. Nature, 425, 846; Thayer, S.P., et al. 2003. Nature, 425, 851; Watkins, D.N., et al. 2003. Nature

Material Matters Volume 15 number 2 Batteries & Solar Cells

dispersion amine 425 900305-250UL 4 μM in PBS, dispersion amine 450 900304-250UL 1 mg/mL in H2O, dispersion carboxylic acid 400 900298-1ML 1 mg/mL in H2O, dispersion carboxylic acid 425 900299-1ML

Protein Depletion for Plasma and Serum Proteomic Analysis

2484S. 9. Liotta LA, Ferrari M, Petricoin EF: Clinical proteomics: Written in blood. Nature 2003, 425:905. 10. Lathrop JT, Anderson NL, Anderson NG, Hammond DJ: Thera- peutic potential of the plasma

XP725 Antibody List Lot 129K4831

(Diphosphorylated ERK-1&2) M9692 5594 MAPK1 M NP_002736.3,NP_620407.1 , y y y 423 MAP Kinase, Monophosphorylated Threonine M3557 5594 MAPK1 M NP_002736.3,NP_620407.1 , y y y 425 MAP Kinase (ERK1+ERK2)

XP725 Antibody List Lot 129K4830

XP725 Antibody List Lot 089K4791

List of Antibodies

MAP Kinase, Activated (Diphosphorylated ERK-1&2) M9692 M y y y 423 MAP Kinase, Monophosphorylated Threonine M3557 M y y y 424 MAP Kinase (ERK-1) M7927 P y y y 425 MAP Kinase (ERK1+ERK2) M5670 P y y y 426

XP725 Antibody List

NP_620407.1,NP_036082.1,NP_00 M y y y 424 MAP Kinase (ERK-1) M7927 50689, 26417, 5595 MAPK3,Mapk3 NP_059043.1,NP_036082.1,NP_002737.2 P y y y 425 MAP Kinase (ERK1+ERK2) M5670 50689, 26417, 5595 MAPK3,Mapk3

Advanced Applications of Engineered Nanomaterials

toluene) 380 387 - 406 18 1.8-2.3 2.7 ~50% CdS 400 Dispersion (25 mg in 5 mL toluene) 400 407 - 425 18 2.3-2.9 2.7 ~50% CdS 420 Dispersion (25 mg in 5 mL toluene) 420 426 -

XP725 Antibody List 013M4793

036082.1,NP_002737.2,NP_4462 M y y y 424 MAP Kinase (ERK-1) M7927 50689, 26417, 5595 MAPK3,Mapk3 NP_059043.1,NP_036082.1,NP_002737.2 P y y y 425 MAP Kinase (ERK1+ERK2) M5670 50689, 26417, 5595 MAPK3,Mapk3

Halal Certificate

, 98% W515000 A16526 HC-24SICG77 424. BUTYL BUTYRATE 98%, FCC, FG W218618 B39157 HC-24SIRN40 425. BUTYL BUTYRATE, NATURAL W218626 C44260 HC-24SIBM66 426. BUTYL BUTYRYLLACTATE 98%, FCC, FG W219002

Halal Certificate

, 98% W515000 A16526 HC-22SILZ75 424. BUTYL BUTYRATE 98%, FCC, FG W218618 B39157 HC-22SIC238 425. BUTYL BUTYRATE, NATURAL W218626 C44260 HC-22SIZE64 426. BUTYL BUTYRYLLACTATE 98%, FCC, FG W219002

XP725 Worksheet for Lot Number 071M4826

p 198 2 1 1 6 Caldesmon C6542 199 2 1 1 7 Calmodulin C7055 200 2 1 1 8 Calmodulin C7055 201 2 1 2 1 Calnexin C4731 202 2 1 2 2 Calnexin C4731 203 2 1 2 3 Calponin C2687 204 2

Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation

gradient: Initial composition: 0 – 8 min 55% A 45% B isocratic, flow increases from 213 μL/min to 425 μL/min, 8.1 – 20 min 65% A 35% B isocratic, flow 850 μL/min Pressure: 8913 psi Column

Chrombook 2015 - The world of chromatography in your hands

MERCK S.A. Calle 10 No. 65 – 28 Apartado Aéreo 9896 BOGOTÁ D.C., COLOMBIA Phone +57 (0) 1 425 4770 Telefax +57 (0) 1 425 5407 E-mail mcsa@emd.com.co Internet www.emdmillipore.co COSTA RICA MERCK S.A. 12